chrisvoncsefalvay/vaers-outcomes huggingface dataset:
they have trouble breathing  but was not that bad; having muscle weakness; when they close their eyes they feel very dizzie; experiencing  a rush all over their body that is not that bad, but small, that started in their face and that it is bumpy; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (they have trouble breathing  but was not that bad), MUSCULAR WEAKNESS (having muscle weakness,), DIZZINESS (when they close their eyes they feel very dizzie), RASH (experiencing  a rush all over their body that is not that bad, but small, that started in their face and that it is bumpy) and MYALGIA (body aches) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012f21a) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Oct-2021, the patient experienced DYSPNOEA (they have trouble breathing  but was not that bad), MUSCULAR WEAKNESS (having muscle weakness,), DIZZINESS (when they close their eyes they feel very dizzie), RASH (experiencing  a rush all over their body that is not that bad, but small, that started in their face and that it is bumpy) and MYALGIA (body aches). At the time of the report, DYSPNOEA (they have trouble breathing  but was not that bad), MUSCULAR WEAKNESS (having muscle weakness,), DIZZINESS (when they close their eyes they feel very dizzie), RASH (experiencing  a rush all over their body that is not that bad, but small, that started in their face and that it is bumpy) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drug details were reported. No treatment details were reported.
Within 30-34 hours of the PNEUMOVAX 23, patient's appetite was virtually gone. He was very irritable and just kept saying "I'm just not hungry." Within the next couple of weeks, we noticed OCD behavior. Within the first month after, he was battling severe nausea almost daily and near syncope and thus he started missing many school days. Also within the next month or so, he had suspected seizure activity, confusion, back pain, leg and foot pain, insomnia, major fatigue, skin flushing (especially on the neck), red eyes, a couple of positive throat swabs for strep (first time in his life he had ever had a throat swab), emotional lability, vocal tics, choreiform movements, POTS symptoms and restrictive eating. His BMI dropped to the 1st percentile and he wasn't able to finish the school year (7th grade). After many months of countless doctor's appointments, two ER visits and a four-day hospital stay searching for answers as what was going on with our son, he was officially diagnosed in with autoimmune encephalopathy in June 2017, six months after the PNEUMOVAX. With treatment (long course antibiotics and many supplements), many of the symptoms have subsided or improved, but life still isn't the same. He is back at school for 8th grade but has missed about half of the school year due to the insomnia, nausea, pain, and frequent infections that remain. He has never missed anything close to this amount of school and was a Gifted and honors student prior to this adverse event. This year, he had to drop his Honors Math class due to frequent absences and he is carrying F's in several classes due to absences and not being able to complete the work.
Consumer reports that w/in 1 hrs p/Acel-immune/OPV, pt exp vomiting, fever & diarrhea; sx persisted for approx 24 hrs; tx included APAP;
Pt says it hurt when she received vaccine. She came back on 10/30/12 and said was still sore and bruised (pale greenish bruise about the size of a nickel). Pt also said she called 911 the previous weekend because it hurt.
Patient called pharmacy 07/30/21 with dizziness, headache, slurred speech and blurred vision.  Pharmacy technician was on phone with patient while the pharmacist called 911.  He was then hospitalized.
Recipient had reaction after 1st and 2nd dose. Employee stated she received her 2nd dose of vaccine on her left arm on 1/12 and developed a cellulitis on 1/13. She reported after her 1st dose she had a cellulitis develop 5 days after she received her dose in the right arm. That vaccine was administered 12/21.
On 09/27/2021, a week after the vaccination, I noticed joint pain in my left wrist and left Achilles tendon in my left foot.  10/21/2021, today I have an appoint to have CRP and ESR- inflammatory markers.   I have an appointment on Monday, 10/25/2021 to see the doctor before I get the 2nd Dose of the Moderna.
Breakthrough case admission after 2 vaccines Moderna 4/21/21 Lot# 006C21A;  Moderna 5/19/21 Lot# 005C21A
BUD for the vaccine was 02/08/2023. Vaccine was administered one day post BUD.
The patient is immuncomprised, received additional dose of pfizer before due.  Accompained by parents, who insisted she is due for her 3rd  additional dose, her vaccination card indicated she received  first  dose 05/13/21 and second dose 06/03/21  and is eligible to received an additional 3rd dose  been immuncomprised.  But after vaccine administration, record shows 3rd dose was administered on 11/23/21. The patient was monitored for 15mintues,  no adverse reaction or acute ditress noted.
5/28 pt with sig pain to her left upper arm at the site of injection of Tdap she received 2 days ago at our office. Pain, erythema, warmth. No systemic sx. Rx-BACTRIM.
I lost my breath constantly for 2 days. I got up from my bed and walked 4 feet to my closet and was completely out of breath. I could not breathe in deeply because my chest hurt so badly. If I got excited in any manner I lost all breath, turned beet red, and begin to sweat profusely. Each episode lasted about 5 minutes, I had to sit down in front of fresh air and be completely still until my breath came back. I could not go out anywhere because as soon as I began walking  I would lose breath immediately and begin to sweat profusely. I am now fearful to get my 2nd shot because the 2nd dose is more intense. If I experienced this on the first dose then will I wind up on a ventilator on the 2nd dose?
Patient treated by AMR EMT for facial flushing and "rash" to chest and neck post second Pfizer vaccine. She reported an anaphylactic reaction to a vaccine in the past (not for COVID). She denied lip or tongue swelling. Per EMT vitals WNL, she declined transportation. County RN followed up with her at 1415 and she reports the flushing to be receding. She denied lip, tongue, or throat swelling and verbalized understanding that she should call her doctor.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2010, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a hospital, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2011, the patient was treated at a hospital for the onset of a vesicular rash, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt states she has burning in her chest substernal about 24 hrs after getting the vaccine. Pt states the pain was about 7/10 and subsides about an hour or so later. Pt denies sob, radiating pain, n/v, fever, chills, GI upset, vision change, skin reaction, h/a, acid taste in mouth. Pt says she has been fine ever since without any residual symptoms.  Symptoms: CHEST PAIN, UNSPECIFIED(R079).
Headaches; chills; extreme fatigue within 24 hours. Extreme arm pain and redness at injection site still at 48 hours.
From telephone contact received at manufacturer on 12/31/02, it was reported that a 4 year old male child was vaccinated with Tripedia, MMR, and OPV on 6/20/96. The lot numbers are not available at this time. The pt reportedly had subclinical seizure disorder diagnosed prior to vaccination on 6/20/96. The disorder was diagnosed from EEg, as epileptic symptoms were subclinical. At some point after vaccinations were received, the parents consulted a neurologist, who prescribed medication (name of medication unknown at this time). THe pt began to experience overt epilepticc seizures that have continued periodically since that time. The reporter, father of the pt, will send additional info regarding events and treatments associated with this report. Seriousness criteria: other medically significant (OMIC).
This case was considered medically important. Information regarding PREVNAR 7 was received from a healthcare professional regarding a patient who experienced blisters and skin peeling on legs, knees and back of neck diagnosed as a latex allergy. The patient received a dose of an unspecified date. The patient experienced blisters and skin peeling on legs, knees and back of neck which was diagnosed as a latex allergy. Outcome was unknown. It has been determined that US-WYE-H0883109, is a duplicate report of US-WYE-H08805109. Therefore, the reports are being consolidate into US-WYE-H08805109, which will remain the official case of record. No additional information was available at the time of this report.
102F temperature, chills, headaches, tiredness, can't sleep at night.  The headaches are weird in that I will get a sharp pain in my head that goes away in a second.
Headache on right side but is now gone Chills No fever Muscle pain in right side of neck. Can barely move neck. Feels like it needs to be supported in a brace.
I had no soreness following H1N1 injection.  About a week later the muscle at injection site became very painful.  This is not continuous, but rather positional.  It is difficult and painful for me to reach behind or toward the back, which was never a problem before.  This situation has not worsened or diminished.  The pain can wake me up at night if I have my arm in a certain position.  It has affected my range of motion - this is in my right arm.  I don't know if anyone has reported this kind of reaction and I am hoping that the pain eventually subsides.
4 months old received fluzone quadriovalent/no AE; Initial information received on 16-Apr-2020 regarding an unsolicited valid non-serious case received from a nurse.  It was reported that 4 months old male received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (Product administered to patient of inappropriate age) on 16-APR-2020 for prophylactic vaccination via intramuscularly[batch number UT6653BA and expiry date 30-JUN-2020].  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, HIB VACCINE CONJ (TET TOX), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (MRC 5), TETANUS VACCINE TOXOID (PENTACEL) ; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) ; and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ).  It was an actual medication error case due to inappropriate age at vaccine administration.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Unknown dates of COVID vaccine. Pt hospitalized for finger injury. Tested positive for COVID upon admission. Asymptomatic at this time
FLARE; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and CONDITION AGGRAVATED (FLARE) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease and Ulcerative colitis.    No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In September 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In September 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On an unknown date, the patient experienced CONDITION AGGRAVATED (FLARE). In 2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. At the time of the report, CONDITION AGGRAVATED (FLARE) was resolving.            Concomitant medication was not reported. Treatment details were not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pt reports 2 days after she received the vaccine she developed intermittent, mild stabbing pain under the left collar bone/left chest area, states pain was worse when taking a deep breath, did not require OTC, and resolved on it's own. The patient states the next evening the pain returned, pain was under the breast bone/rib cage and in the back, pain would come and go, better after resting, worse with activity, and again resolved spontaneously and has not returned.
This spontaneous report was received from a Physician and refers to an unspecified patient of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not provided. On 06-FEB-2017, the patient was vaccinated with improperly stored dose of M-M-R II (lot # M028131 with expiry date 03-JUN-2018) (dose, route and anatomical location not reported) for prophylaxis. Exact time frame and temperature at which the vaccine underwent excursion was unknown. However it was reported that the lot # M028131 underwent a temperature excursion of 32 degrees Fahrenheit to 35 degrees Fahrenheit for a cumulative time frame of 4 hours and a temperature excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for a cumulative time frame of 5 hours on different days since 26-JAN-2017 to 27-MAR-2017. Maximum individual time frame was reported as 60 minutes for each cycle. There was no previous temperature excursion. The call was not because of data logger. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA005435: US-009507513-1705USA005437: US-009507513-1705USA005438: US-009507513-1705USA005439: US-009507513-1704USA014447: US-009507513-1705USA005462: US-009507513-1705USA005463.
pt devel hives 2 hrs p/vax;no other sxs;was seen @ hosp & dx'd as all rxn, T100 @ visit; scheduled for allergy testing on 20NOV95;
This spontaneous report as received from a nurse practitioner refers to approximately 10 unspecified patients. On an unknown date, the patients were vaccinated with approximately 10 doses of PROQUAD (Merck) (Lot # H015875, expiration date 24-FEB-2014) that were exposed to -4C for 720 hours (30 days) which was not supported. No adverse effects were reported. This is one of several reports received from same source. Additional information has been requested.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature 26 F(Fahrenheit)for a total of 135 hours. No adverse effect reported. Follow-up received. Certified Medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding a 14 years old, male patient with no pertinent medical history reported. On 15-MAR-2013 the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). On an unknown date the patient received another dose of GARDASIL (lot number and expiration date not reported) (route and dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
Bruised site 1.75" within 48 hours. Hot to touch, painful and burning for 3 days. Slightly raised and in perfect circle. ER visit x 2 for check up and pain medication. Increased to 3" diameter. 11/21/02 resolving with pain and is itchy.
side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (side effects). At the time of the report, ADVERSE EVENT (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment was reported. Patient wants to know treatment for the side effects
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 01-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Admitted to hospital with COVID-19 pneumonia. Symptoms onset 10/11/2021. Tested positive 10/15/2021 requiring oxygen via high flow nasal cannula. Treated with Remdesivir + Baricitinib and dexamethasone.
TB test; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported that received received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. Certified Nursing Assistant got the first dose of the covid vaccine on January 2nd and also she needs to get her TB test. She was told to wait 2weeks between the application and the TB test but the 2 weeks period ends on January 15th and she needs to have the test before that day, so she was wondering if she could get the test done a couple of days early. The outcome of the event was unknown.   Information about lot/batch number has been requested.
Pain, swelling, induration and warmth at the injection site in the (L)eft deltoid approx. 12 mins following injection.
Had no issues until i went to bed. Early morning on 9/2..  I was shivering so intensely that my muscles hurt despite a 72 degree temperature in he house. This was my first time noticing the chest pain.. Woke up the next morning after sleeping an astonishing amount. In excess of 10 hours feeling like I had ran a marathon. At which point I noticed my feet were covered in a measles like rash of red dots.. Missed work..  The red dots were still there the next day.. Took bendryl to try and control the itching. Began having severe chain pain following a dizzy spell taking care of hospital linen.. . Was seen in the ED. They released me after a chest xray. Will follow up with my doctor when the weekend is over..
I received the Pfizer Bivalent booster on 10/3/2022. On 12/5/2022, I began to get major sinus congestion. The sinus congestion continued for several days. My wife and I were planning to visit friends, but we decided to test ourselves for COVID-19 beforehand to be on the safe side. I took a home antigen test on 12/19/2022, and the result was positive. On 12/23/2022, I called the nurse helpline provided through my insurance company. I asked if I should take Paxlovid. Since I have the pre-existing conditions of kidney disease and congestive heart failure, the nurse suggested that I should take half the dose that is normally recommended, so I was prescribed half the normal dose of Paxlovid. I was hesitant to take it, though, without consulting my doctor. On 12/26/2022, my doctor called me, and I asked for his opinion. He told me that if I took the Paxlovid, I would possibly have COVID-like symptoms. I didn't want that, so I opted not to take it. Instead, I just treated my symptoms with Tylenol and ibuprofen. Unfortunately, though, they were not effective at all. I also used my albuterol inhaler as needed. The congestion was finally gone by 12/27/2022. During my time with COVID-19, I never had any severe symptoms. I just had difficulty breathing through my nose on account of the nasal congestion. I had no chest congestion, though.
Initial unsolicited report received from a nurse on 18 October 2016. This case involves a 17-year-old female patient, who was vaccinated with dose of FLUZONE QIV MDV (batch number: UI669AA, expiry date, route and site of administration were not reported) on 13 September 2016. Patient's medical history and concomitant medications were not reported. On 03 October 2016, 20 days following vaccination patient was seen again by office complaining of muscle weakness and diagnosed with Guillain-Barre syndrome. On 03 October 2016, patient was hospitalized. Laboratory data and corrective treatment were not reported. The outcome of the events was not reported. Documents held by sender: none. Sender's Comments: This case concerns 18 year old female patient who received INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED and 20 days later developed Guillain-Barre syndrome. However in this particular case very limited information has been provided. Further information regarding etiological work up, concurrent condition at the time of vaccination, concomitant medication and investigation results to rule out the alternative cause are needed for complete assessment of the case.
Approximately 12 hours later, I started experiencing shortness of breath and felt my airway was closing off. I immediately took 25mg of Benadryl and monitored signs and symptoms.